AiDoc
Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries.
The round was led by health tech and life sciences VC fund aMoon.
The agency also warned consumers of unregulated diabetes products and outlined plans for AI device regulation.
Both companies are ramping up the pace of their FDA clearances.
AIdoc's tool flags potential cases of pulmonary embolism to ensure prompt review and intervention.